Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.
about
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingModeling Kidney Disease with iPS CellsG-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingInduced Pluripotency and Gene Editing in Disease Modelling: Perspectives and ChallengesCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineMolecular pathogenesis of long QT syndrome type 2Inherited heart disease - what can we expect from the second decade of human iPS cell research?Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypesModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesEvaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytesHuman-based approaches to pharmacology and cardiology: an interdisciplinary and intersectorial workshop.Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testingDual optical recordings for action potentials and calcium handling in induced pluripotent stem cell models of cardiac arrhythmias using genetically encoded fluorescent indicatorsThe Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome CardiomyocytesCalcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia.Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Low extracellular potassium prolongs repolarization and evokes early afterdepolarization in human induced pluripotent stem cell-derived cardiomyocytes.Investigating human disease using stem cell models.iPCS Cell Modeling of Inherited Cardiac Arrhythmias.Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters.Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.Comparing ESC and iPSC-Based Models for Human Genetic DisordersAntisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy.Genome-wide association studies and contribution to cardiovascular physiologyToward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT SyndromeEffects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytesA new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Pluripotent stem cells as a platform for cardiac arrhythmia drug screeningCardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes.New approaches to establish genetic causality.Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease.From iPSC towards cardiac tissue-a road under construction.Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs)Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte FunctionConcise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.
P2860
Q26750618-E7229A60-D3C7-493A-9604-ACB3A4FF425FQ26770384-0685E41F-EEC9-4DEC-85E2-DFBE373C1EE1Q26772221-FC15C782-2B19-42EF-96CC-0093DC874B7EQ26775061-8E7FCAB0-6FD3-4C72-BCD5-B7900B868980Q26798131-0459925E-1A50-445B-BCF6-9928CB83815DQ28076397-5842B6F2-321C-4EC4-A391-750B81902CDFQ28077303-CA6FBD8A-4110-45B6-94E6-8B23E6629AC8Q28079217-1106848B-B736-45AD-A8FB-D68D213AD649Q28081697-8CCD1AAF-E7D4-4CCE-A61F-2DC69330C725Q28255887-AC572E05-D5D7-4D0A-A1E8-095EF0176007Q28542837-118D461A-E5B6-4FDC-8D2C-343B07E556B2Q28596483-30471FC1-A9B6-4749-A122-75F0EC00C46FQ30586646-447A7A61-8E59-48EA-9B8E-5C50F524D084Q30645275-4EF62D48-1879-493F-9D35-67EBCFA184ABQ30828413-CF33E0AE-C45B-4E0C-BF17-FEED267DE400Q33164771-2E3A38F5-BCCE-4600-B7DF-0BDDBFA7099FQ33704567-4D42B0C0-3AF1-4CF1-8766-54335B4A7D56Q33830565-9E885CF0-B61E-4C63-A02B-8893114711A4Q34431170-285E8323-7129-48AD-AFC6-1518CA8A0A86Q34431713-40CF280C-1F2E-4387-B48E-05831A1467D1Q34494232-3455A53E-2CB3-4C7A-B894-EB2CC5A2CAC1Q34752070-DEA22D7F-C196-45AB-B63A-F366E1B49235Q35750530-3423F93E-C8BA-4AC3-9996-1AE59A873948Q35822565-4A6F9453-59B7-4558-B86F-283FB873D25FQ36017794-1B8951C4-3E85-4B1E-851D-A083AD32BE9FQ36141836-B16B69CB-05BB-444C-861B-875644E3E10EQ36632323-8A7B46B3-9029-4189-A84F-15B7C0B9A2CFQ37228986-C745474A-4180-4036-8DAC-49B59F5E1704Q37573646-CFD38F29-9B9C-45FC-868B-B16DEF0F4629Q38235190-C04BC517-B59A-4693-8A9D-7D8401E69BA7Q38393181-66C81734-D00E-4009-ADE9-D4659D33BCF4Q38416344-9F52231F-5776-4C4C-B5EB-FF605711D458Q38454536-2293EB43-3C51-4C54-9B8E-EEE805239535Q38530607-EBE31543-AA0C-4114-8B51-217C8554C06AQ38675863-C5422CEF-2F73-408D-AB21-5706F4FDC31DQ38750884-DC227D1A-4E28-4329-B522-75C137D6BF17Q38819976-7829103D-8F74-4A5D-BCC4-92D8F4513284Q38826141-099B108F-D14C-4DDD-A98F-DDA23BB547D8Q38850545-1F33FFC7-3180-4351-B58F-8D58E126E7E2Q38874111-DB65767A-5077-4FD0-948B-80A0A90E3F02
P2860
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@ast
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@en
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@nl
type
label
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@ast
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@en
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@nl
prefLabel
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@ast
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@en
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@nl
P2093
P2860
P50
P356
P1433
P1476
Isogenic human pluripotent ste ...... mutation in long-QT syndrome.
@en
P2093
Andrea Welling
Christian B Jung
Cristina D'Aniello
Dorien Ward-van Oostwaard
Jessica Haas
Leon G J Tertoolen
Simona Casini
P2860
P304
P356
10.1038/EMBOJ.2013.240
P407
P50
P577
2013-11-08T00:00:00Z